• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Dems divided on Trump’s executive order aimed at slashing drug prices

by May 15, 2025
written by May 15, 2025

President Donald Trump’s executive order aimed at slashing U.S. drug prices has divided Democrats on Capitol Hill, with some cautiously optimistic while others dismissed the move as a bluster.

Most Democratic lawmakers who spoke with Fox News Digital about the order noted they had not read into the details, but the reactions were mostly split.

‘It certainly seems more bark than it is bite,’ Rep. Richard Neal, D-Mass., the top Democrat on the House Ways & Means Committee, told Fox News Digital. 

Neal said it ‘strikes me as though it’s another example of the executive order that garners a lot of attention’ with little impact, though he noted he was still looking into the details.

Rep. George Latimer of New York, a first-term Democrat who unseated a former member of the progressive ‘Squad,’ ex-Rep. Jamaal Bowman, D-N.Y., signaled he was hopeful about the initiative.

‘If we can keep drug costs low, that’s a positive thing,’ Latimer said. ‘I don’t, you know, oppose everything the president does, things that help people lower costs. If that’s what this turns into, then yes, it’s a worthwhile idea. But I have to be honest, I’ve got to read it more closely to understand it better.’

Trump announced Monday that he was directing the Department of Health and Human Services to set price targets for pharmaceutical companies.

The president said the order would have pharmaceutical companies set drug prices on par with the lowest prices in other developed countries.

He said, ‘some prescription drug and pharmaceutical prices will be reduced almost immediately by 50 to 80 to 90%.’

Democratic Rep. Lou Correa, D-Calif., told Fox News Digital when asked about the order, ‘It’s always a good thing to reduce drug costs.’

‘I think it’s a move in the right direction, let’s just see the details,’ Correa added.

Rep. Lloyd Doggett, D-Texas, like Neal, told Fox News Digital he was more skeptical.

‘My feeling is that, like his…announcements during his first term, there’s much talk and no meaningful reduction of drug prices,’ Doggett said. ‘It remains to be seen whether any patient in America will see a price reduced on a single drug as a result of this order. So, until I see action, I will not believe that he has truly committed to reducing prices.’

House Democratic Caucus Chair Pete Aguilar, D-Calif., also said he did not believe Trump was ‘serious’ when asked.

‘All of this is just a disingenuous effort…on the part of House Republicans and Donald Trump, to pretend like they were looking out for people,’ Aguilar said. ‘If they were serious about it, the policy would be placed within their reconciliation bill. It’s not. This is just a performance effort by the president.’

Meanwhile, Rep. Ro Khanna, D-Calif., introduced a House bill to make Trump’s order permanent.

‘I rise today, to introduce as legislation, President Trump’s executive order for the most favored nation status on drug pricing,’ Khanna said on the House floor.

‘My legislation will codify President Trump’s executive order, which basically says that Americans should not pay more for drugs than people in other countries and other parts of the world.’

In an exclusive Fox News interview with Sean Hannity, Trump argued that his executive order should offset Democrats’ concerns with his ‘big, beautiful’ budget reconciliation bill being pushed by Republicans.

Democrats have accused Republicans of using the bill to gut critical programs like Medicaid for millions of people who need it, while the GOP has contended it was just trying to eliminate waste and abuse within the system.

‘It’s the Democrats’ fault that people are being ripped off for years and years. And now I hear Democrats saying, ‘Oh, well, we’re going to not go for the bill.’ It’s going to be very hard for them not to approve of the big, beautiful bill that we’re doing,’ Trump said. ‘We’re doing the biggest tax cuts in the history of our country because people are going to be getting a 50 to a 90% reduction on drug prices.’

When reached for comment on Democrats’ responses, White House spokesman Kush Desai told Fox News Digital, ‘Democrats talk; President Trump delivers. Instead of again putting politics over the American people, Democrats should work with the Trump administration to build on the President’s historic action to lower drug prices and end global freeriding off the backs of Americans.’

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Supreme Court Chief Justice Roberts reins in Sotomayor after repeated interruptions
next post
House Dems open investigation into Trump’s acceptance of $400 million jet from Qatar

related articles

Trump’s apocalyptic Iran warning raises stakes for sweeping...

April 7, 2026

Graham eyes ‘down payment’ on Trump-backed SAVE Act...

April 7, 2026

Democrat whose parents fled Iran moves to oust...

April 7, 2026

Midterm alarm bells: Democrats face steep favorability deficit...

April 7, 2026

American journalist kidnapped in Iraq is set free,...

April 7, 2026

Dem Senate primary erupts in key state as...

April 7, 2026

Trump-backed candidate aims to pad GOP’s fragile House...

April 7, 2026

Ilhan Omar calls Trump an ‘unhinged lunatic,’ urges...

April 7, 2026

White House unleashes on Stacey Abrams in latest...

April 7, 2026

Former Virginia Gov Glenn Youngkin hints at political...

April 7, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • EURUSD and GBPUSD: New Support and Targets for Friday

    October 4, 2024
  • Mike Wilson explains why US stocks may tumble in early April

    March 17, 2026
  • Trump brings back Diet Coke button to White House Oval Office

    January 21, 2025
  • Render (RNDR) hits crucial user milestone ahead of much-anticipated token swap

    July 18, 2024
  • White House sends mixed signals in Russia ‘hoax’ blame game

    July 24, 2025

Popular Posts

  • 1

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 2

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    CoreWeave eyes $1.5B bond raise to ease debt load following lacklustre IPO: report

    May 9, 2025
  • 5

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024

Categories

  • Economy (829)
  • Editor's Pick (8,502)
  • Investing (1,661)
  • Stock (1,017)

Latest Posts

  • Tesla stock fails to rebound even as broader market rockets: here’s why

    April 8, 2026
  • FCC is investigating Disney and ABC for DEI initiatives

    March 29, 2025
  • Figma stock falls as Google AI Stitch sparks design software fears

    March 19, 2026

Recent Posts

  • Trump admin urges restoring ballroom construction in emergency motion: ‘Time is of the essence’

    April 5, 2026
  • CrowdStrike stock: 3 simple reasons why AI can’t disrupt it

    February 23, 2026
  • Kazakhstan joining Abraham Accords, US official confirms

    November 6, 2025

Editor’s Pick

  • Trump to unleash $12B farm rescue as China trade reset hits US growers

    December 8, 2025
  • MIKE DAVIS: Kash Patel is restoring the FBI despite constant attacks

    February 25, 2026
  • U.S. online stores put ‘out of stock’ signs as Nintendo Switch 2 sales hit record highs

    June 11, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock